Communicable diseases
Researchers from England have published a study in the journal Vaccine, demonstrating the effectiveness of whole cell and acellular pertussis vaccines in providing mucosal immunization of murine neonates. The study found that neonatal mice tolerated mucosal vaccination well and showed a significant cellular infiltrate in the lungs compared to PBS
Communicable diseases
Women infected with HIV may transfer lower levels of protective antibodies to their babies during pregnancy, making them more vulnerable to infections, according to a study published in 2004. The research, conducted by Shahana Choudhury and her team at Meharry Medical College, found that mothers with the lowest CD4 positive
Communicable diseases
De novo immune hepatitis, a type of autoimmune hepatitis, has been linked to a genetic mismatch in liver transplant patients. Specifically, a study from Spain found that a mismatch in the glutathione S-transferase T1 (GSTT1) gene between donor and recipient increases the risk of this condition. Researchers analyzed a cohort
Communicable diseases
A team of scientists from Innsbruck Medical University has made a groundbreaking discovery in the fight against fungal infections. By genetically blocking the iron metabolism of Aspergillus fumigatus mold, they have found a promising approach to developing new therapies against deadly fungal infections. This breakthrough has significant implications for patients
Communicable diseases
Researchers in the United States have demonstrated that the enzyme inhibitor zoledronic acid can prevent the development of cervical cancer in a mouse model. This breakthrough finding suggests that zoledronic acid may have potential as an 'unconventional' inhibitor for the treatment of cervical cancer and possibly other diseases
Communicable diseases
Hepatitis C virus (HCV) is a persistent infection that affects millions of people worldwide. Researchers in Japan have discovered that HCV alters the function of dendritic cells, a crucial part of the immune system, making it difficult for the body to fight off the infection. This impairment in dendritic cell
Communicable diseases
In a breakthrough study, researchers from Innogenetics NV, led by G. Leroux-Roels, have successfully tested a novel vaccine containing the hepatitis C virus E1 protein in a Phase I clinical trial. The study, conducted on 20 healthy male volunteers, demonstrated the vaccine's tolerability and immunogenicity, inducing a strong
Communicable diseases
A novel approach to preventing herpes simplex virus 2 (HSV-2) infection has been discovered through a study conducted by researchers at McMaster University in Canada. The study found that intravaginal immunization with a viral subunit protein plus CpG oligodeoxynucleotides (ODN) induces protective immunity against HSV-2 in mice. This breakthrough has
Communicable diseases
Researchers at Loma Linda University and Harvard University have successfully expressed the HIV-1 gp120 V3 cholera toxin B subunit fusion gene in a transgenic potato. The team used Agrobacterium tumefaciens-mediated transformation to transfer the CTB-gp120 fusion gene into Solanum tuberosum cells, which resulted in the expression of the fusion protein
Communicable diseases
Researchers in England have found that adenoviruses encoding CD40L or IL-2 are effective against B cell lymphoma. In their study, investigators infected A20 B lymphoma cells with a replication-defective adenovirus encoding murine CD40L, but not IL-2, and observed an antigen presentation phenotype with upregulation of MHC Class I/II, induction
Communicable diseases
Researchers have developed a double-modified adenovirus that enhances gene transfer in cervical cancer, according to a study published in the International Journal of Cancer. The adenovirus, Ad5.RGD.pK7, was found to improve tumor targeting in vivo, resulting in a significantly improved tumor/liver ratio in mice. This breakthrough has
Communicable diseases
Researchers have engineered recombinant respiratory syncytial viruses (RSVs) with the region responsible for type 2 T-cell responses and pulmonary eosinophilia deleted from the attachment (G) protein. This modification aims to elicit a balanced immune response, reducing the risk of exaggerated respiratory tract disease and unwanted inflammation in the airways. The
